Provided by Tiger Trade Technology Pte. Ltd.

Athira Pharma, Inc.

6.75
0.0000
Volume:- -
Turnover:495.51K
Market Cap:26.62M
PE:-0.70
High:6.75
Open:6.75
Low:6.75
Close:6.75
52wk High:8.36
52wk Low:2.20
Shares:3.94M
Float Shares:1.09M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.6552
EPS(LYR):-25.1917
ROE:-89.42%
ROA:-42.21%
PB:0.99
PE(LYR):-0.27

Loading ...

Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Nov 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 31, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 25, 2024

Correspondence

Form CORRESP - Correspondence
Oct 18, 2024

Major Issues Report

Form 8-K - Current report
Oct 08, 2024

Major Issues Report

Form 8-K - Current report
Sep 17, 2024

Major Issues Report

Form 8-K - Current report
Sep 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
May 29, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Major Issues Report

Form 8-K - Current report